Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Roger Kravtzoff"'
Autor:
Didier Betbeder, Michel Major, Roger Kravtzoff, Ignacio De Miguel, Valerie Rieumajou, Laurent Imbertie
Publikováno v:
Pharmaceutical Research. 17:817-824
Purpose. Supramolecular Biovectors (SMBV™) consist of cross-linkedcationic nanoparticles surrounded by a lipid membrane. Thepurpose was to study the structure of the lipid membrane and tocharacterise its interaction with the nanoparticles in order
Autor:
Sandrine Sperandio, Arnaud Debin, Karl Melber, Marinette Moynier, Laurence Cazales, Didier Betbeder, Zbigniew A. Janowicz, Jocelyn Vaz Santiago, Roger Kravtzoff
Publikováno v:
Vaccine. 20(21-22)
New cationic nanoparticles (SMBV™) were evaluated for use as a nasal vaccine delivery system for two recombinant proteins: HBsAg and β-galactosidase. Each protein was formulated with SMBV™ and intranasally administrated to non-anesthetized mice.
Autor:
Sébastien Leuillet, Philippe Ancian, Roger Kravtzoff, Roy Forster, Odile Boutherin-Falson, Sandrine Arthaud
Publikováno v:
Toxicology Letters. 180:S121-S122
Autor:
Laurent Imbertie, Myriam Berton, Cuider Allal, Roger Kravtzoff, Claire Dartigues, Gilles Favre, Sophie Sixou
Publikováno v:
Biochimica et biophysica acta. 1355(1)
Antisense oligodeoxynucleotides are potential therapeutic agents, but their development is still limited by both a poor cellular uptake and a high degradation rate in biological media. The strategy that we propose to face these problems is to use sma
Publikováno v:
Erythrocytes as Drug Carriers in Medicine ISBN: 9781489900463
Red blood cells (RBCs) are easy to obtain, their cellular volume is large enough to load high quantities of active substances and their half-life is well defined. Due to their physiological role, they have access to most parts of the body. If transfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8095e4a7a54f01ff470cb4b6d340d9c1
https://doi.org/10.1007/978-1-4899-0044-9_5
https://doi.org/10.1007/978-1-4899-0044-9_5
Publikováno v:
NanoBiotechnology. 1:317-318
• Basulin® is the only once-a-day human insulin with a proof of efficacy in human clinical trials. • Basulin has demonstrated a good safety and tolerability and confirmed the 24 hours efficacy in Phase IIa during 14 days with 20 patients. • Ba
Publikováno v:
The Use of Resealed Erythrocytes as Carriers and Bioreactors ISBN: 9781461363217
Ricin is a cytotoxic protein derived from Ricinus Communis, that inhibits eukaryotic protein synthesis.1 Indeed, the catalytic subunit of the toxin, ricin A chain, inactivates eukaryotic ribosomes by removing a single adenine residue from 28S ribosom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0cdb8e13df3699b583bfc1589d702ee
https://doi.org/10.1007/978-1-4615-3030-5_34
https://doi.org/10.1007/978-1-4615-3030-5_34
Publikováno v:
The Use of Resealed Erythrocytes as Carriers and Bioreactors ISBN: 9781461363217
Soon after the advent of the diagnostic tool Magnetic Resonance Imaging (MRI), magnetic resonance contrast agents were developed and provided to the radiologists an additional tool that would significantly improve the accuracy of this observation. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b828498988cc7f678a9af8ab562cc3a3
https://doi.org/10.1007/978-1-4615-3030-5_42
https://doi.org/10.1007/978-1-4615-3030-5_42